Cromolyn Sodium is named as a drug or biological intervention in 2 clinical trials in our USA trial register, 1 of which is recruiting. Lead sponsors include Carcinex Inc (1) and PhenoNet, Inc. (1). Registered phases: Phase 1 and Phase 2. Conditions studied include Locally Advanced Non-Small Cell Lung Cancer; Lung Adenocarcinoma; Amyotrophic Lateral Sclerosis (ALS).
| NCT ID | Study | Phase | Status |
|---|---|---|---|
| NCT07142291 | PHENOGENE-1A (Cromolyn) Treatment in Patients With Mild to Moderate ALS (ClinicalTrials.gov ↗) Amyotrophic Lateral Sclerosis (ALS) |
Phase 2 | Recruiting |
| NCT07675876 | Inhaled Cromolyn Sodium in Patients With Locally Advanced Lung Cancer (ClinicalTrials.gov ↗) Locally Advanced Non-Small Cell Lung Cancer, Lung Adenocarcinoma |
Phase 1 | Not yet open |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Condition (as registered) | Trials |
|---|---|
| Locally Advanced Non-Small Cell Lung Cancer | 1 |
| Lung Adenocarcinoma | 1 |
| Amyotrophic Lateral Sclerosis (ALS) | 1 |
| Lead sponsor | Trials |
|---|---|
| Carcinex Inc | 1 |
| PhenoNet, Inc. | 1 |
| Register | Cromolyn Sodium trials |
|---|---|
| Clinical trials in USA | 2 |
A trial with sites in more than one country appears in each of those registers.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Cromolyn Sodium works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Cromolyn Sodium (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 24 Sep 2026.